Syngene International Ltd (Syngene), a subsidiary of Biocon Ltd, is a clinical research, development and manufacturing programs company. The company’s contact research services include discovery of medicinal chemistry, small molecule development, discovery biology, safety assessment, formulation development, chemical development, stability studies, integrated discovery and development, polymer research, clinical development, bioinformatics and antibody-drug conjugates and oligonucleotide synthesis services. Syngene also includes peptides, oligonucleotides, antibody-drug conjugates, PROTACS, CAR-T, rare and orphan diseases. The company serves pharmaceutical and biotechnology, nutrition, cosmetics, agrochemical, animal health and specialty chemical industries. Syngene is headquartered in Bengaluru, Karnataka, India.
Headquarters
India
Address
Syngene International Ltd, , Biocon Park, Sez, Bommasandra Industr, Bangalore, Karnataka, 560099
Website
www.syngeneintl.com
Telephone
91 80 68918000
No of Employees
6,847
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
SYNGENE (NSE)
Revenue (2022)
$406.9M
22.6%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
17.3%
(2022 vs 2021)
Market Cap*
$3.4B
Net Profit Margin (2022)
XYZ
-4.3%
(2022 vs 2021)
* As of and is in US$
Syngene International Ltd premium industry data and analytics
Products and Services
| Services |
|---|
| Discovery Chemistry |
| Safety Assessment |
| Chemical Development |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Asset Purchase | In December, the company acquired a Unit 3 biologics manufacturing facility in Bengaluru, India from Stelis Biopharma Limited. |
| 2023 | Plans/Strategy | In September, the company announced its plans to invest INR788 crore on expansion of its operations in Genome Valley, Hyderabad. |
| 2023 | Plans/Strategy | In September, the company announced its plans to build research laboratories in Genome Valley, Hyderabad, India. |
Competitor Comparison
| Key Parameters | Syngene International Ltd | Aurobindo Pharma Ltd | Pfizer Ltd India | Vimta Labs Ltd | Transgene Biotek Ltd |
|---|---|---|---|---|---|
| Headquarters | India | India | India | India | India |
| City | Bangalore | Hyderabad | Mumbai | Hyderabad | Hyderabad |
| State/Province | Karnataka | Telangana | Maharashtra | Telangana | Telangana |
| No. of Employees | 6,847 | 15,690 | 1,702 | 1,368 | - |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Jonathan Hunt | Director; Chief Executive Officer; Managing Director | Executive Board | 2020 | - |
| Sibaji Biswas | Chief Financial Officer; Director | Executive Board | 2024 | - |
| Andrew Webster | Chief Human Resources Officer | Senior Management | - | - |
| Kenneth Barr | Senior Vice President - Discovery Services | Senior Management | - | - |
| Priyadarshini Mahapatra | Company Secretary; Compliance Officer | Senior Management | 2019 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer